| Serial Number | 79286017 |
| Word Mark | CELLVIE |
| Filing Date | Wednesday, December 18, 2019 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Friday, October 15, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Preparations for medical purposes employing mitochondria; cardiovascular treatment preparations employing mitochondria; cardiovascular pharmaceuticals employing mitochondria used in treating arrhythmias; pharmaceutical and biological preparations for the treatment of cardiovascular diseases, ischemia-and reperfusion-injuries, chronic cardiac diseases, mitochondrial myopathies, tumors or diabetes mitochondria for transplant purposes for medical use; pharmaceutical and biological preparations for the application of mitochondria transplantation for medical purposes in vessel and organ transplantations; implantable living tissue and mitochondria for the promotion of tissue growth, for medical use; mitochondria, for medical use; biological tissue cultures containing mitochondria for medical purposes; pharmaceutical and biological preparations containing mitochondria for tissue regeneration and protection for medical purposes; living cell components, namely, mitochondria, including genetically-modified mitochondria or pharmaceutically treated mitochondria, for medical use in humans and veterinary use in animals |
| Translation of Words in Mark | The wording "CELLVIE" has no meaning in a foreign language. |
| Goods and Services | Medical testing services for diagnostic and disease treatment purposes relating to cardiovascular diseases, ischemia-and reperfusion-injuries, chronic cardiac diseases, mitochondrial myopathies and tumors; medical analysis of human or animal tissues for mitochondria transplant treatment purposes of cardiovascular diseases, ischemia-and reperfusion-injuries, chronic cardiac diseases, mitochondrial myopathies and tumors; medical analysis of cells and cell components in relation to mitochondria for diagnostic and treatment purposes of cardiovascular diseases, ischemia-and reperfusion-injuries, chronic cardiac diseases, mitochondrial myopathies and tumors |
| Goods and Services | Prosthetic tissues based on mitochondria for parietal, vascular and visceral use; medical apparatus and devices for the processing of tissue- or cell-samples for the isolation of mitochondria or other cell components, namely, nucleus, ribosomes, rough endoplasmic reticulum, smooth endoplasmic reticulum, golgi apparatus, vacuole, chloroplasts, peroxisome, lysosome, centrosome, centriole, cilium, microvillus, cytosol, cytoskeleton, microtubules, filaments, exosomes, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), micro RNA (mRNA), transfer RNA (tRNA), nucleic acid, cell membrane, plasma membrane and secretory vesicles from muscle tissue or other human or animal tissues, as well as from cells and cell cultures; filter for the isolation of cell components, namely, mitochondria, nucleus, ribosomes, rough endoplasmic reticulum, smooth endoplasmic reticulum, golgi apparatus, vacuole, chloroplasts, peroxisome, lysosome, centrosome, centriole, cilium, microvillus, cytosol, cytoskeleton, microtubules, filaments, exosomes, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), micro RNA (mRNA), transfer RNA (tRNA), nucleic acid, cell membrane, plasma membrane and secretory vesicles from cells for medical purposes; medical apparatus and devices for the transplantation or injection of cells or cell component, namely, mitochondria, nucleus, ribosomes, rough endoplasmic reticulum, smooth endoplasmic reticulum, golgi apparatus, vacuole, chloroplasts, peroxisome, lysosome, centrosome, centriole, cilium, microvillus, cytosol, cytoskeleton, microtubules, filaments, exosomes, deoxyribonucleic acid (DNA), ribonucleic acid (RNA), micro RNA (mRNA), transfer RNA (tRNA), nucleic acid, cell membrane, plasma membrane and secretory vesicles in humans or animals |
| Goods and Services | Scientific and technological services, namely, scientific and clinical research, analysis and testing in the field of mitochondrial isolation or transplantation; scientific and clinical research and development services in the field of mitochondria; conducting clinical trials for others in the field of cardiovascular diseases, ischemia-and reperfusion-injuries, heart transplantations, tumor treatments, mitochondrial myopathies analysis of human tissues for scientific and clinical research relating to mitochondria; scientific and clinical research, analysis and testing services relating to the isolation and cultivation of human and animal mitochondria |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 22, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 22, 2020 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 22, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 22, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | cellvie Inc. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 98 - Unknown |
| Address | US |
| Party Name | Cellvie UG (haftungsbeschränkt) |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | DE |
| Event Date | Event Description |
| Thursday, May 21, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, May 22, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 22, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, May 26, 2020 | APPLICATION FILING RECEIPT MAILED |
| Thursday, May 28, 2020 | NON-FINAL ACTION WRITTEN |
| Friday, May 29, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, June 29, 2020 | REFUSAL PROCESSED BY MPU |
| Monday, June 29, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, July 17, 2020 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Friday, July 31, 2020 | REFUSAL PROCESSED BY IB |
| Friday, October 16, 2020 | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED |
| Thursday, December 3, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 5, 2021 | ASSIGNED TO LIE |
| Friday, March 5, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 5, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 29, 2021 | FINAL REFUSAL E-MAILED |
| Monday, March 29, 2021 | FINAL REFUSAL WRITTEN |
| Monday, March 29, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, December 22, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, December 22, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Saturday, October 15, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, October 17, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, September 20, 2024 | CHANGE OF OWNER RECEIVED FROM IB |
| Monday, November 7, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, October 15, 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Friday, October 15, 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Sunday, January 9, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |